What You Should Know:
– Innovaccer, a healthcare data platform, unveils Sara Scribe, an AI assistant poised to revolutionize healthcare documentation.
– Sara Scribe, also known as InScribe, transcends the limitations of standard dictation software. This innovative tool uses advanced AI to not only transcribe doctor-patient conversations in real-time but also analyze them and deliver actionable insights, streamlining workflows and freeing up valuable clinician time.
Beyond Transcription: Clinical Intelligence at Your Fingertips
Sara Scribe is more than just a transcriptionist; it’s a clinical advisor. It analyzes conversations and leverages EHR and claims data to identify:
– Quality gaps: Potential areas for improvement in patient care.
– Coding gaps: Opportunities to optimize reimbursement through accurate coding.
– Potential diagnoses: Early flags for possible health conditions, enabling proactive care.
This real-time guidance empowers clinicians to make informed decisions, optimize care delivery, and improve patient outcomes.
Two Modes to Fit Every Need
Innovaccer caters to both large and small healthcare providers with two distinct InScribe modalities:
Enterprise: Seamlessly integrated with Innovaccer’s existing Point-of-Care assistant, InNote, this version elevates user experience with ambient documentation and clinical insights drawn from comprehensive EHR and claims data.
Individual: Designed for independent practitioners and smaller groups, this standalone web-based tool boasts an intuitive mobile companion app. Users can sign up and begin using InScribe within minutes, making it accessible and convenient.
“InScribe isn’t just a transcription tool—it’s a game-changer in the AI assistant space. It not only documents the conversation but also nudges the provider with real-time clinical insights during a visit,” Abhinav Shashank, Cofounder and CEO, Innovaccer. “We understand burnout is at an all-time high. With InScribe, we aim to reduce the administrative and cognitive load of clinicians and redirect their time back to patients.”
